SUBSCRIBE
SUBSCRIBE

Stylus Medicine

NEWS
NextGen
BioSpace’s NextGen Class of 2026 Attracts Big Bucks From Tight Wallets
From biotech veterans to embattled modalities to a new wave of RNAi therapeutics, BioSpace’s NextGen Class of 2026 emerged during a tough fundraising environment in 2025. Check out the 15 battle-tested companies that caught our eye.
January 7, 2026
 · 
2 min read
 · 
Annalee Armstrong
IN THE PRESS
Press Releases
Stylus Medicine to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 7, 2026
 · 
1 min read
Press Releases
Stylus Medicine Launches to Develop Precision, In Vivo Genetic Medicines and Unlock the Full Potential of CAR-T Therapy
May 14, 2025
 · 
6 min read
Press Releases
Stylus Medicine Announces Presentations at the American Society of Gene & Cell Therapy (ASGCT) 28th Annual Meeting
May 13, 2025
 · 
3 min read
Biotech Bay
Aerin Medical Receives FDA Clearance of Next-Generation RhinAer® Stylus for Treatment of Patients with Chronic Rhinitis
September 8, 2022
 · 
6 min read
Pharm Country
Stylus Research Reveals Five Trends in the “Legal Cannabis Era”
June 19, 2018
 · 
2 min read
AWARDS
  • NextGen Class of 2026 Badge
JOBS